Evidence map›Paper›PMID 36981803›Full record

ReviewInternational journal of environmental research and public health2023

Quality of Life in Patients with Pancreatic Cancer-A Literature Review.

Elżbieta Cipora, Aleksandra Czerw, Olga Partyka, Monika Pajewska, Anna Badowska-Kozakiewicz, Marta Fudalej, Katarzyna Sygit, Mateusz Kaczmarski, Edyta Krzych-Fałta, Anna Jurczak and 8 more

Open access · goldFull text readReview
In one paragraph

Review in International journal of environmental research and public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
7.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. The value of FOLFIRINOX in advanced pancreatic cancer: balancing efficacy, toxicity, and quality of life.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  7. Review
  8. Palliative care in pancreatic cancer: effects on symptom burden, survival, and place of death.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 1 country.

Elżbieta CiporaMedical Institute, Jan Grodek State University in Sanok, 38-500 Sanok, Poland.ORCID 0000-0002-7794-550X
Aleksandra CzerwDepartment of Economic and System Analyses, National Institute of Public Health NIH-National Research Institute, 00-791 Warsaw, Poland.ORCID 0000-0002-6189-6678
Olga PartykaDepartment of Economic and System Analyses, National Institute of Public Health NIH-National Research Institute, 00-791 Warsaw, Poland.ORCID 0000-0001-6359-2902
Monika PajewskaDepartment of Economic and System Analyses, National Institute of Public Health NIH-National Research Institute, 00-791 Warsaw, Poland.ORCID 0000-0002-7735-5219
Anna Badowska-KozakiewiczDepartment of Oncology Propaedeutics, Medical University of Warsaw, 01-445 Warsaw, Poland.
Marta FudalejDepartment of Oncology Propaedeutics, Medical University of Warsaw, 01-445 Warsaw, Poland.
Katarzyna SygitFaculty of Health Sciences, Calisia University, 62-800 Kalisz, Poland.ORCID 0000-0001-7173-2266
Mateusz KaczmarskiMedical Institute, Jan Grodek State University in Sanok, 38-500 Sanok, Poland.ORCID 0000-0003-4498-7110
Edyta Krzych-FałtaDepartment of Basic Nursing, Faculty of Health Sciences, Medical University of Warsaw, 01-445 Warsaw, Poland.
Anna JurczakDepartment of Clinical Nursing, Pomeranian Medical University in Szczecin, 71-210 Szczecin, Poland.ORCID 0000-0003-1935-5285
Katarzyna Karakiewicz-KrawczykDepartment of Clinical Nursing, Pomeranian Medical University in Szczecin, 71-210 Szczecin, Poland.
Sylwia Wieder-HuszlaDepartment of Clinical Nursing, Pomeranian Medical University in Szczecin, 71-210 Szczecin, Poland.ORCID 0000-0002-6084-5780
Tomasz BanaśDepartment of Radiotherapy, Maria Sklodowska-Curie Institute-Oncology Centre, 31-115 Cracow, Poland.ORCID 0000-0002-6656-2490
Ewa BandurskaCenter for Competence Development, Integrated Care and e-Health, Medical University of Gdansk, 80-204 Gdansk, Poland.ORCID 0000-0002-6268-3447
Weronika CiećkoCenter for Competence Development, Integrated Care and e-Health, Medical University of Gdansk, 80-204 Gdansk, Poland.ORCID 0000-0002-1496-1924
Dariusz Artur KosiorMossakowski Medical Research Institute, Polish Academy of Science, 02-106 Warsaw, Poland.
Piotr KułakDepartment of Cardiology and Hypertension with Electrophysiological Lab, Central Research Hospital, The Ministry of the Interior and Administration, 02-507 Warsaw, Poland.
Andrzej DeptałaDepartment of Oncology Propaedeutics, Medical University of Warsaw, 01-445 Warsaw, Poland.ORCID 0000-0003-2640-2043
Medical University of Warsaw · PLPomeranian Medical University · PLGdańsk Medical University · PLJan Grodek State Vocational Academy in Sanok · PLMossakowski Medical Research Institute, Polish Academy of Sciences · PLNarodowy Instytut Zdrowia Publicznego PZH – Państwowy Instytut Badawczy · PLThe Maria Sklodowska-Curie National Research Institute of Oncology · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pancreatic cancer is the malignant disease with the highest mortality rate, and it ranks third in the world after lung and colon cancer. Identified factors that increase the risk of developing pancreatic cancer include chronic pancreatitis, radiation therapy to the pancreatic area due to another cancer, diabetes mellitus, obesity, smoking, and age. The objective of this study was to present the current state of knowledge on the quality of life of patients diagnosed with pancreatic cancer, factors that determine QoL, and ways of coping with the disease. The low curability and low survival rates of pancreatic cancer significantly affect the quality of life of patients, often in the form of significant deterioration, especially in terms of mental changes, cognitive functions, and coping with the disease. Cognitive decline with comorbid depression is also typical for patients with this type of cancer. Research has shown that the health-related quality of life of patients with pancreatic cancer is low, so further research is needed to improve the situation in this area.

Indexed as

Diabetes MellitusPancreatic NeoplasmsPancreatitis, ChronicComorbidityHumansQuality of Lifeliterature reviewmental adjustment to diseasepain managementpancreatic cancerquality of life

Identifiers

PMID36981803
PMCPMC10048931
OpenAlexW4323848817

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read25
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.